Skip to main content
Top
Published in: Clinical Neuroradiology 2/2017

01-06-2017 | Clinical Case

Freiburg Neuropathology Case Conference

Widespread White Matter Lesions in a Patient with Progressive Paraparesis and Cortical Blindness

Authors: C. A. Taschner, P. Süß, B. Sajonz, H. Urbach, C. P. Simon-Gabriel, M. Prinz

Published in: Clinical Neuroradiology | Issue 2/2017

Login to get access

Excerpt

A 62-year-old female patient presented with an acutely deteriorating paraparesis which had evolved slowly over 6 months. On admission, she showed complete paraplegia, new cortical blindness and psychomotor retardation. Diagnostic imaging revealed multiple cerebral lesions. Extensive cerebrospinal fluid (CSF) analyses showed no evidence of an infectious origin, but revealed identical oligoclonal bands in serum and CSF denoting a systemic disease in combination with blood–brain barrier disruption. The laboratory workup for vasculitis was inconspicuous. Elevated levels of serum soluble interleukin 2 receptor and neopterin pointed to sarcoidosis, but were regarded as non-specific. Due to pneumonia, the patient required antibiotic treatment and was temporarily transferred to the intensive care unit. A stereotactic biopsy was performed under general anesthesia. The initial postoperative course was uneventful; however, with dexamethasone treatment a slight improvement of the cortical blindness occurred. The initial histopathological diagnosis was small-vessel vasculitis. Consequently, the patient was treated with cyclophosphamide and prednisolone, and transferred to a rehabilitation hospital. Further manifestations of vasculitis were not found. After histopathological determination of the final diagnosis the patient was retransferred from the rehabilitation hospital. She showed a further improvement of the cortical blindness. After initiation of the definitive treatment there was a marked improvement of the cortical blindness, whereas the paraparesis remained unchanged. …
Literature
1.
go back to reference Jennette JC. Overview of the 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Clin Exp Nephrol. 2013;17:603–6.CrossRefPubMedPubMedCentral Jennette JC. Overview of the 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Clin Exp Nephrol. 2013;17:603–6.CrossRefPubMedPubMedCentral
3.
go back to reference Mangla R, Kolar B, Almast J, Ekholm SE. Border zone infarcts: pathophysiologic and imaging characteristics. Radiographics. 2011;31:1201–14.CrossRefPubMed Mangla R, Kolar B, Almast J, Ekholm SE. Border zone infarcts: pathophysiologic and imaging characteristics. Radiographics. 2011;31:1201–14.CrossRefPubMed
4.
go back to reference Bester M, Petracca M, Inglese M. Neuroimaging of multiple sclerosis, acute disseminated encephalomyelitis, and other demyelinating diseases. Semin Roentgenol. 2014;49:76–85.CrossRefPubMed Bester M, Petracca M, Inglese M. Neuroimaging of multiple sclerosis, acute disseminated encephalomyelitis, and other demyelinating diseases. Semin Roentgenol. 2014;49:76–85.CrossRefPubMed
5.
go back to reference Chen JJ, Carletti F, Young V, Mckean D, Quaghebeur G. MRI differential diagnosis of suspected multiple sclerosis. Clin Radiol. 2016;71:815–27.CrossRefPubMed Chen JJ, Carletti F, Young V, Mckean D, Quaghebeur G. MRI differential diagnosis of suspected multiple sclerosis. Clin Radiol. 2016;71:815–27.CrossRefPubMed
6.
go back to reference Ponzoni M, Ferreri AJ, Campo E, Facchetti F, Mazzucchelli L, Yoshino T, Murase T, Pileri SA, Doglioni C, Zucca E, Cavalli F, Nakamura S. Definition, diagnosis, and management of intravascular large B‑cell lymphoma: proposals and perspectives from an international consensus meeting. J Clin Oncol. 2007;25:3168–73.CrossRefPubMed Ponzoni M, Ferreri AJ, Campo E, Facchetti F, Mazzucchelli L, Yoshino T, Murase T, Pileri SA, Doglioni C, Zucca E, Cavalli F, Nakamura S. Definition, diagnosis, and management of intravascular large B‑cell lymphoma: proposals and perspectives from an international consensus meeting. J Clin Oncol. 2007;25:3168–73.CrossRefPubMed
7.
go back to reference Shimada K, Kinoshita T, Naoe T, Nakamura S. Presentation and management of intravascular large B‑cell lymphoma. Lancet Oncol. 2009;10:895–902.CrossRefPubMed Shimada K, Kinoshita T, Naoe T, Nakamura S. Presentation and management of intravascular large B‑cell lymphoma. Lancet Oncol. 2009;10:895–902.CrossRefPubMed
9.
go back to reference Ponzoni M, Arrigoni G, Gould VE, Del Curto B, Maggioni M, Scapinello A, Paolino S, Cassisa A, Patriarca C. Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol. 2000;31:220–6.CrossRefPubMed Ponzoni M, Arrigoni G, Gould VE, Del Curto B, Maggioni M, Scapinello A, Paolino S, Cassisa A, Patriarca C. Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol. 2000;31:220–6.CrossRefPubMed
10.
go back to reference Yamamoto A, Kikuchi Y, Homma K, O’uchi T, Furui S. Characteristics of intravascular large B‑cell lymphoma on cerebral MR imaging. Am J Neuroradiol. 2012;33:292–6.CrossRefPubMed Yamamoto A, Kikuchi Y, Homma K, O’uchi T, Furui S. Characteristics of intravascular large B‑cell lymphoma on cerebral MR imaging. Am J Neuroradiol. 2012;33:292–6.CrossRefPubMed
11.
go back to reference Ferreri AJ, Campo E, Seymour JF, Willemze R, Ilariucci F, Ambrosetti A, Zucca E, Rossi G, López-Guillermo A, Pavlovsky MA, Geerts ML, Candoni A, Lestani M, Asioli S, Milani M, Piris MA, Pileri S, Facchetti F, Cavalli F, Ponzoni M; International Extranodal Lymphoma Study Group (IELSG).. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’. Br J Haematol. 2004;127(2):173–83.CrossRefPubMed Ferreri AJ, Campo E, Seymour JF, Willemze R, Ilariucci F, Ambrosetti A, Zucca E, Rossi G, López-Guillermo A, Pavlovsky MA, Geerts ML, Candoni A, Lestani M, Asioli S, Milani M, Piris MA, Pileri S, Facchetti F, Cavalli F, Ponzoni M; International Extranodal Lymphoma Study Group (IELSG).. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’. Br J Haematol. 2004;127(2):173–83.CrossRefPubMed
12.
go back to reference Fonkem E, Dayawansa S, Stroberg E, Lok E, Bricker PC, Kirmani B, Wong ET, Huang JH. Neurological presentations of intravascular lymphoma (IVL): meta-analysis of 654 patients. BMC Neurol. 2016;16:9.CrossRefPubMedPubMedCentral Fonkem E, Dayawansa S, Stroberg E, Lok E, Bricker PC, Kirmani B, Wong ET, Huang JH. Neurological presentations of intravascular lymphoma (IVL): meta-analysis of 654 patients. BMC Neurol. 2016;16:9.CrossRefPubMedPubMedCentral
13.
go back to reference Hundsberger T, Cogliatti S, Kleger GR, Fretz C, Gähler A, Anliker M, Fournier JY, von Moos R, Tettenborn B, Driessen C. Intravascular lymphoma mimicking cerebral stroke: report of two cases. Case Rep Neurol. 2011;3(3):278–83.CrossRefPubMedPubMedCentral Hundsberger T, Cogliatti S, Kleger GR, Fretz C, Gähler A, Anliker M, Fournier JY, von Moos R, Tettenborn B, Driessen C. Intravascular lymphoma mimicking cerebral stroke: report of two cases. Case Rep Neurol. 2011;3(3):278–83.CrossRefPubMedPubMedCentral
Metadata
Title
Freiburg Neuropathology Case Conference
Widespread White Matter Lesions in a Patient with Progressive Paraparesis and Cortical Blindness
Authors
C. A. Taschner
P. Süß
B. Sajonz
H. Urbach
C. P. Simon-Gabriel
M. Prinz
Publication date
01-06-2017
Publisher
Springer Berlin Heidelberg
Published in
Clinical Neuroradiology / Issue 2/2017
Print ISSN: 1869-1439
Electronic ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-017-0589-5

Other articles of this Issue 2/2017

Clinical Neuroradiology 2/2017 Go to the issue